FDA Inspection 753983 — Rosemont Pharmaceuticals Ltd.
The FDA completed an inspection of Rosemont Pharmaceuticals Ltd. on Oct 13, 2011 in Leeds. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 13, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Leeds (United Kingdom)